Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00508573 · ClinicalTrials.gov registry record
Registry for Women Who Are At Risk Or May Have Lynch Syndrome
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 323
- Enrollment target
NCT00508573: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00508573 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 323 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00508573 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 323 participants
- Enrollment target
Study Summary
The goal of this study is to create a registry of information about women who have or are at risk for Lynch syndrome, in order to study gynecologic cancer risks. This is an investigational study. Up to 1000 patients will take part in this study. All patients will be enrolled at MD Anderson.
Interventions
- BEHAVIORAL Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 323 participants |
| Start Date | 2007-05 |
| Est. Completion | 2024-08-05 |
What the finished NCT00508573 record still lists
NCT00508573 is an observational study that tracks outcomes without assigning an intervention. The registered 323 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire is the first listed.
NCT00508573 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00508573 about?
NCT00508573 is a clinical study titled "Registry for Women Who Are At Risk Or May Have Lynch Syndrome". The goal of this study is to create a registry of information about women who have or are at risk for Lynch syndrome, in order to study gynecologic cancer risks. This is an investigational study. Up to 1000 patients will take part in this study. All patients will be enrolled at MD Anderson.
What is the current status of trial NCT00508573?
This trial is currently completed. The enrollment target is 323 participants. The study started on 2007-05. Estimated completion is 2024-08-05.
What interventions are being tested in trial NCT00508573?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00508573?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04164173 · 324 participants · NA
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
- NCT04708054 · 324 participants · Phase 2
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
- NCT05261399 · 324 participants · Phase 3
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
- NCT05353322 · 324 participants · NA
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia